Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Bone Marrow Transplant ; 37(7): 661-8, 2006 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16489358

RESUMO

In 56 pediatric and adolescent patients (median age 7 years, range 1-21) with various solid tumors, peripheral blood stem cells (PBSC) were mobilized with granulocyte colony-stimulating factor (G-CSF) alone, and the yields of PBSC and engraftment kinetics following autologous peripheral blood stem cell transplantation (PBSCT) were evaluated retrospectively. Granulocyte colony-stimulating factor (10 microg/kg) was injected subcutaneously for mobilization when patients showed no influence of previous chemotherapy, and administration was continued for 5 days. The peaks of CD34+ cells and colony-forming units-granulocyte/macrophage in the blood were observed on days 4 through 6 of G-CSF administration in all patients. Peripheral blood stem cell harvest was commenced on day 5 of G-CSF treatment. Compared to the results in patients mobilized by chemotherapy plus G-CSF (N=18), the progenitor cell yields were lower in patients mobilized with G-CSF alone. However, there were no significant differences in WBC and ANC engraftment compared to the chemotherapy plus G-CSF mobilization group. Platelet recovery following autologous PBSCT was delayed in patients mobilized with G-CSF alone. The median time taken for ANC and platelet counts to reach 0.5 x 10(9) and 20 x 10(9)/l was 12 days (range: 9-28) and 15 days (8-55), respectively, in all patients who received PBSC mobilized by G-CSF alone. In summary, mobilization with G-CSF alone can mobilize sufficient CD34+ cells for successful autografting and sustained hematological reconstitution in pediatric and adolescent patients with solid tumors, and even in heavily pre-treated patients.


Assuntos
Fator Estimulador de Colônias de Granulócitos/administração & dosagem , Mobilização de Células-Tronco Hematopoéticas/métodos , Neoplasias/terapia , Transplante de Células-Tronco de Sangue Periférico , Adolescente , Adulto , Antígenos CD34/sangue , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Criança , Pré-Escolar , Feminino , Sobrevivência de Enxerto , Humanos , Lactente , Cinética , Masculino , Neoplasias/diagnóstico , Neoplasias/imunologia , Transplante de Células-Tronco de Sangue Periférico/métodos , Estudos Retrospectivos , Condicionamento Pré-Transplante , Transplante Autólogo , Transplante Homólogo , Resultado do Tratamento
2.
Biochem Biophys Res Commun ; 336(1): 204-9, 2005 Oct 14.
Artigo em Inglês | MEDLINE | ID: mdl-16129414

RESUMO

Histone macroH2A1.2 (macroH2A) is an unusual histone H2A variant with a large non-histone macrodomain at its carboxyl terminal. MacroH2A1.2 is enriched in facultative heterochromatin, including inactivated X chromosomes in mammalian females and senescence-associated heterochromatin foci. We show here that a small population of macroH2A1.2 is mono-ubiquitinated in human HeLa cells. Mass spectrometry analysis revealed that the specific targeting sites for the mono-ubiquitination are Lys115 and Lys116 of the histone domain. A corresponding Lys119 conserved in histone H2A is also mono-ubiquitinated by Ring protein in the polycomb group complex. We suggest that the mono-ubiquitination of macroH2A1.2 and histone H2A has similar or synergistic implications, but that the multiple ubiquitination sites in macroH2A1.2 might confer a variety of functions upon macroH2A1.2 to modulate chromatin states.


Assuntos
Histonas/metabolismo , Ubiquitina/metabolismo , Sequência de Aminoácidos , Western Blotting , Cromatografia de Afinidade , Eletroforese em Gel de Poliacrilamida , Células HeLa , Histonas/química , Histonas/isolamento & purificação , Humanos , Dados de Sequência Molecular , Nucleossomos/metabolismo , Homologia de Sequência de Aminoácidos , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz
3.
Bone Marrow Transplant ; 25(7): 787-90, 2000 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10745266

RESUMO

We report here a patient who suffered from PCR- confirmed human herpesvirus type 6 (HHV-6) meningoencephalitis after allogeneic purified CD34+ cell transplantation from his HLA-mismatched sibling donor, even though he had been on intense prophylaxis with i.v. ganciclovir (GCV), acyclovir (ACV) and gamma-globulin containing a specific antibody against HHV-6. Serological evaluation disclosed that both the donor and recipient had IgG antibody against HHV-6 before transplantation. His blood WBC count started to transiently increase on day 10, and all blood components had decreased by day 20. He then developed a severe headache and high blood pressure, and sporadic abnormal neurological findings including nystagmus and delirium. An analysis of cerebrospinal fluid (CSF) revealed 8 cells/microl, a glucose level of 130 mg/dl and a protein level of 201 mg/dl (normal, 50 mg/dl) on day 26. At the time, HHV-6 was detected only in CSF by a PCR-based method and he was diagnosed as having meningoencephalitis due to the local reactivation of HHV-6. Although he failed to respond to high-dose therapy with ACV (60 mg/kg/day) and gamma-globulin, the DNA of this virus disappeared from the CNS upon treatment with GCV (30 mg/kg/day) combined with the intraventricular infusion of alpha-interferon. His clinical course was further complicated with meningoencephalitis due to staphylococcus epidermidis, and he died of tentorial herniation on day 79 without the recovery of blood components. This experience may indicate that intense prophylaxis to prevent reactivation of HHV-6 in the CNS is essential for the management of such profoundly immunosuppressed patients.


Assuntos
Anemia Aplástica/terapia , Transplante de Células-Tronco Hematopoéticas , Infecções por Herpesviridae/etiologia , Herpesvirus Humano 6 , Teste de Histocompatibilidade , Meningoencefalite/etiologia , Aciclovir/uso terapêutico , Adolescente , Antígenos CD/imunologia , Antígenos CD34/imunologia , Antivirais/uso terapêutico , Quimioterapia Combinada , Ganciclovir/uso terapêutico , Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Infecções por Herpesviridae/diagnóstico , Herpesvirus Humano 6/genética , Herpesvirus Humano 6/isolamento & purificação , Humanos , Imageamento por Ressonância Magnética , Masculino , Meningoencefalite/diagnóstico , Reação em Cadeia da Polimerase/métodos , Viroses/prevenção & controle , gama-Globulinas/uso terapêutico
4.
Blood ; 93(4): 1157-63, 1999 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-9949157

RESUMO

The relationship between stem cell mobilization with granulocyte colony-stimulating factor (G-CSF) and the endogenous production of interleukin-8 (IL-8), macrophage inflammatory protein-1alpha (MIP-1alpha), tumor necrosis factor-alpha (TNF-alpha), and interferon-gamma (IFN-gamma) was studied in normal donors for allogeneic peripheral blood stem cell (PBSC) transplantation. G-CSF was administered to 20 normal donors at a dose of 10 microg/kg/d for 5 days with aphereses on days 5 and 6 of G-CSF treatment. Cytokine serum levels were measured using an enzyme-linked immunosorbent assay (ELISA) before and during G-CSF treatment. Before treatment, the average level of IL-8 was 7.1 pg/mL, increasing to 207.0 pg/mL on day 5 and 189.1 pg/mL on day 6. Serum IL-8 levels correlated CD34(+) cell numbers (P =.0151 and P =.0005 on days 5 and 6, respectively) and colony-forming unit-granulocyte-macrophage (CFU-GM) numbers (P =.0019 and P =.0010 on days 5 and 6, respectively). Furthermore, preapheresis serum IL-8 levels correlated with the yield of CD34(+) cells (P =.0027). In contrast, before treatment, the average levels of MIP-1alpha, TNF-alpha, and IFN-gamma were 70.1, 4.03, and 3.84 pg/mL, respectively, and no significant changes in the levels of these cytokines were observed during G-CSF treatment. These studies suggest that IL-8 production may be critical to G-CSF-induced stem cell mobilization, although the underlying mechanism could not be clarified.


Assuntos
Fator Estimulador de Colônias de Granulócitos/farmacologia , Mobilização de Células-Tronco Hematopoéticas , Células-Tronco Hematopoéticas/imunologia , Interferon gama/biossíntese , Interleucina-8/biossíntese , Proteínas Inflamatórias de Macrófagos/biossíntese , Fator de Necrose Tumoral alfa/biossíntese , Adolescente , Adulto , Quimiocina CCL3 , Quimiocina CCL4 , Criança , Pré-Escolar , Transplante de Células-Tronco Hematopoéticas , Células-Tronco Hematopoéticas/efeitos dos fármacos , Humanos , Interferon gama/imunologia , Interleucina-8/imunologia , Proteínas Inflamatórias de Macrófagos/imunologia , Pessoa de Meia-Idade , Fator de Necrose Tumoral alfa/imunologia
5.
Biochem Biophys Res Commun ; 244(1): 226-9, 1998 Mar 06.
Artigo em Inglês | MEDLINE | ID: mdl-9514914

RESUMO

HuD is a neuronal-specific, RNA-binding protein. Here we examined the change in the expression of HuD protein during nerve growth factor-mediated differentiation of PC12 cells. As cells differentiated and extended neurites, expression of HuD gradually increased up to 1.5-fold. When HuD expression was counteracted by antisense oligonucleotide, neurite extension was completely inhibited, yet the morphology of differentiated cells remained unchanged even after that treatment. Furthermore, this morphological change correlated well with the downregulation of cyclin-dependent kinase 2 activity. These results suggest that the HuD is critically involved in the initial phase of neuronal differentiation.


Assuntos
Quinases relacionadas a CDC2 e CDC28 , Proteínas do Tecido Nervoso , Neurônios/citologia , Proteínas de Ligação a RNA/biossíntese , Animais , Diferenciação Celular/efeitos dos fármacos , Tamanho Celular/efeitos dos fármacos , Quinase 2 Dependente de Ciclina , Quinases Ciclina-Dependentes/metabolismo , Proteínas ELAV , Inibidores do Crescimento/farmacologia , Fatores de Crescimento Neural/farmacologia , Neuritos/efeitos dos fármacos , Neuritos/fisiologia , Neurônios/efeitos dos fármacos , Neurônios/enzimologia , Oligonucleotídeos Antissenso/farmacologia , Células PC12 , Proteínas Serina-Treonina Quinases/metabolismo , Proteínas de Ligação a RNA/genética , Proteínas de Ligação a RNA/fisiologia , Ratos
6.
Biochem Biophys Res Commun ; 232(3): 622-5, 1997 Mar 27.
Artigo em Inglês | MEDLINE | ID: mdl-9126324

RESUMO

The differences in the protein expression of cyclins, cyclin-dependent kinases (cdks), and their inhibitors and cdk kinase activities were examined in serum dependent (SD) and independent (PF) clones of the murine fibrosarcoma cell line, Gc-4. The expression of cyclin A in SD was minimal in contrast to PF. Furthermore, cdk2 kinase activity in PF was remarkably lower than that in SD, yet the G1/S transition in PF appeared normal. PF was also resistant against the selective inhibitor of cdk2, butyrolactone I. These findings suggest that tumor cell proliferation and tumor progression can be promoted by the activation of a molecule(s) downstream of cdk2.


Assuntos
Quinases relacionadas a CDC2 e CDC28 , Ciclo Celular/fisiologia , Quinases Ciclina-Dependentes/metabolismo , Proteínas Serina-Treonina Quinases/metabolismo , Proteínas Proto-Oncogênicas , 4-Butirolactona/análogos & derivados , 4-Butirolactona/farmacologia , Animais , Divisão Celular/efeitos dos fármacos , Separação Celular , Meios de Cultura Livres de Soro , Quinase 2 Dependente de Ciclina , Quinase 4 Dependente de Ciclina , Quinases Ciclina-Dependentes/antagonistas & inibidores , Ciclinas/metabolismo , Inibidores Enzimáticos/metabolismo , Inibidores Enzimáticos/farmacologia , Fibrossarcoma/metabolismo , Fibrossarcoma/patologia , Citometria de Fluxo , Camundongos , Proteínas Serina-Treonina Quinases/antagonistas & inibidores , Células Tumorais Cultivadas
8.
Dig Dis Sci ; 37(7): 1105-9, 1992 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-1618060

RESUMO

Primary hepatic lymphoma is a rare disease. We report five cases here and summarize clinical and pathologic features of our own and reported cases from Western countries and Japan. The total number of cases was 68. The age of patients ranged from 7 to 87 years (median 55) with a male-to-female ratio of 3.1:1. Chronic hepatitis or cirrhosis before onset of hepatic lymphoma was noted in 44% of Japanese cases and 9.6% of Western cases. Macroscopically, the liver was occupied by solitary mass (60%), multiple masses (35%), or a diffuse lesion without nodule formation (5%). Histologically all cases were non-Hodgkin's lymphoma with the diffuse large cell type being most common. Three cases (4.4%) were follicular lymphoma. Immunohistochemically about 80% of the cases were B-cell type. Follow-up study showed that hepatic lymphoma had a relatively favorable prognosis when early detection of the disease was possible.


Assuntos
Neoplasias Hepáticas/epidemiologia , Linfoma não Hodgkin/epidemiologia , Feminino , Hepatite B/epidemiologia , Hepatite Crônica/epidemiologia , Humanos , Japão/epidemiologia , Fígado/patologia , Neoplasias Hepáticas/patologia , Linfoma não Hodgkin/patologia , Masculino , Pessoa de Meia-Idade
9.
Radiat Med ; 8(2): 35-9, 1990.
Artigo em Inglês | MEDLINE | ID: mdl-2171041

RESUMO

Two adult cases of primary hepatic rhabdomyosarcoma, one of which was associated with hepatocellular carcinoma and had double malignant tumors, are described with emphasis on the radiologic features. On precontrast computed tomography, the lesion appeared as a well-defined hypodense mass like an abscess, while linear mottled enhancement was observed on the postcontrast scan. Angiography revealed displacement of the hepatic arteries and portal veins, irregular neovascularity in the peripheral portion, and scant tumor stain without dilatation of the feeding artery. Review of the literature revealed only 10 previous reports.


Assuntos
Angiografia , Neoplasias Hepáticas/diagnóstico por imagem , Rabdomiossarcoma/diagnóstico por imagem , Tomografia Computadorizada por Raios X , Idoso , Carcinoma Hepatocelular/diagnóstico por imagem , Meios de Contraste , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias Primárias Múltiplas/diagnóstico por imagem , Intensificação de Imagem Radiográfica
10.
Brain Res ; 455(1): 144-7, 1988 Jul 05.
Artigo em Inglês | MEDLINE | ID: mdl-3416179

RESUMO

Reduced nicotinamide adenine dinucleotide phosphate-diaphorase (NADPH-diaphorase), which is specifically localized in neurons, has been histochemically demonstrated in human brain by using a perfusion-fixation procedure. With such fixed human brainstem, it was possible to study the topographic organization of NADPH-diaphorase-containing neurons that were visualized in fine detail for the first time. In the pontomesencephalic region, positive neurons were observed in nuclei around the decussation and arm of the superior cerebellar peduncle. These nuclei included the pedunculopontine tegmental, lateral parabrachial and oral pontine reticular nuclei. The positive somata were mainly multipolar in shape and medium to large in size. The positive neurons appeared to correspond to cholinergic neurons, at least partly in the brainstem, in terms of both the patterns of distribution and the cellular morphology.


Assuntos
Tronco Encefálico/enzimologia , Mesencéfalo/enzimologia , NADH NADPH Oxirredutases/metabolismo , NADPH Desidrogenase/metabolismo , Ponte/enzimologia , Tronco Encefálico/anatomia & histologia , Histocitoquímica , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA